PaQ? Enables Glycemic Control without Daily Insulin Injections for People with Type 2

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
CeQur SA, a company focused on the development and commercialization of simple insulin delivery devices, announced that the PaQ? Insulin Delivery Device has received CE Mark approval. PaQ has demonstrated the safety and efficacy required for marketing in Europe.

PaQ is a discreet, wearable device that provides three days of consistent, basal insulin delivery as well as easy, on-demand bolus insulin for individuals with type 2 diabetes. The small device comprises a disposable insulin-infuser reservoir attached to a reusable insulin monitor. PaQ is simple to use, making it easy to train patients to start and stay on insulin therapy.

http://www.sacbee.com/2012/11/27/5012595/cequr-receives-ce-mark-for-paq.html
 
Never enough info is there LOL

How big is the reservoir and why exactly only T2 ? - bearing in mind eg my basal rate is 9.6u DD and some T2s need c.200u to do the same thing.
 
Status
Not open for further replies.
Back
Top